| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |